Novel transcript antisense to RBMS2 (ENSG00000298140)

ENSG00000298140, "novel transcript, antisense to RBMS2", is a natural antisense transcript (NAT), a noncoding RNA whose sequence is complementary to the RBMS2 gene. NATs like this one regulate expression of their corresponding protein-coding “sense” genes through various mechanisms, including transcriptional interference, RNA masking, chromatin remodeling, and dsRNA-mediated processes like RNA interference and RNA editing[1][2][3][4]. These transcripts function primarily as post-transcriptional or epigenetic regulators, altering levels, splicing, or accessibility of the sense transcript, and can fine-tune gene expression or dampen noise in gene output[1][4]. There is no evidence that ENSG00000298140 encodes a protein or acts as a receptor, enzyme, transporter, or therapeutic target[1][2][3][4]. Instead, its biological significance lies in modulating the expression or function of the RBMS2 gene—potentially impacting diverse cellular processes indirectly. There are currently no drugs, biomarkers, or diseases directly associated with this transcript. The gene symbol and description appear accurate and not misspelled, though this entry represents a regulatory RNA rather than a canonical drug target. In summary: ENSG00000298140 is a regulatory natural antisense noncoding RNA that controls the expression of the RBMS2 gene via RNA-based mechanisms but is not a direct therapeutic target or conventional molecular entity such as a receptor or enzyme[1][2][3][4].

Other names

novel transcript, antisense to RBMS2ENSG00000298140